Global Fund Appoints Mark Dybul as Executive Director
The organization selects a former leader to steer efforts in fighting HIV, tuberculosis, and malaria.
Updated on Oct. 28, 2026 in People
Live Poll
Do you trust that global health organizations are prioritizing the right countries for aid funding?
The Global Fund to Fight AIDS, Tuberculosis and Malaria has officially appointed Mark Dybul to serve as its executive director. Dybul is expected to assume his new role early next year.
Why it matters
The board selected Dybul to provide experienced leadership as the organization adapts to evolving global health challenges. His appointment aims to drive renewed progress toward ending the world's most persistent infectious diseases.
Mark Dybul brings over 25 years of professional experience in HIV and public health to the leadership role. He previously served as head of the Global Fund from 2013 to 2017.
The players
Mark Dybul
He is a medicine professor at Georgetown University and a co-founder of the Center for Global Health Practice and Impact who previously led the Global Fund.
The Global Fund to Fight AIDS, Tuberculosis and Malaria
This international partnership organization based in Geneva works to accelerate the end of the HIV, tuberculosis, and malaria epidemics.
The details
Dybul, currently a medicine professor at Georgetown University and a co-founder of the Center for Global Health Practice and Impact, will lead the Geneva-based organization. His return follows a period where the fund adjusted its resource allocation toward the world's poorest nations.
Timeline
Mark Dybul served as Global Fund head from 2013 to 2017.
The Global Fund announced the appointment of Mark Dybul on October 28, 2026.
Mark Dybul begins his term as executive director in early 2027.
Market Landscape
The appointment marks a return to the 2013-2017 tenure of Mark Dybul, signaling a strategic choice for continuity in the organization. This decision comes as the fund aims to solidify its position amidst ongoing global aid cuts for prevention programs.
While the leadership change is an internal corporate move, it affects how global health aid is distributed to vulnerable populations. Supporters of disease prevention programs may see shifts in funding priorities as the new leadership team settles into their roles next year.
The takeaway
Selecting a former executive director suggests the board is prioritizing proven institutional knowledge to navigate current funding volatility. The transition will likely focus on stabilizing prevention programs that have recently faced global aid reductions.
Further reading
For more information on high-level appointments and organizational leadership, visit the People section.
Live Poll
Do you trust that global health organizations are prioritizing the right countries for aid funding?
